Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
The tale of two global HIV responses continues to unfold this week, in data released by UNAIDS in the run-up to the 22nd International AIDS Conference […]
Advocates hail South Africa bedaquiline recommendation, replacing toxic injection for patients with drug-resistant tuberculosis
Medicine represents third choice over “deaf or dead” for many patients, health worker/tuberculosis survivor-founded organization says Praising the treatment policy decision of South Africa health officials […]
Tools to diagnose and monitor HIV, hepatitis B and C, and tuberculosis, as well as resistance to first-line TB treatment are among the tests included in […]
The following is a guest post by By Jackie Hellen, MPH of MEASURE Evaluation Community workers and program managers work tirelessly to control HIV at the local […]